Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

ClinicalTrials.gov ID: NCT04390113

Public ClinicalTrials.gov record NCT04390113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplant (HCT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC).

Study identification

NCT ID
NCT04390113
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
AlloVir
Industry
Enrollment
97 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
1 Year and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 18, 2021 (Actual)
Primary completion
Jan 30, 2024 (Actual)
Completion
Jan 30, 2024 (Actual)
Last update posted
May 14, 2024

2021 – 2024

United States locations

U.S. sites
25
U.S. states
21
U.S. cities
24
Facility City State ZIP Site status
City of Hope National Medical Center Duarte California 91010 —
Children's Hospital of Los Angeles Los Angeles California 90027 —
Yale University School of Medicine - Yale Cancer Center New Haven Connecticut 06520 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
University of Miami Miami Florida 33136 —
Moffitt Tampa Florida 33612 —
Northside Hospital Atlanta Georgia 30342 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
University of Kansas Cancer Center Kansas City Kansas 66160 —
Johns Hopkins Medicine Baltimore Maryland 21287 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
Massachusetts General Hospital Boston Massachusetts 02215 —
University of Minnesota Minneapolis Minnesota 55455 —
Children's Mercy Hospital - Kansas City Kansas City Missouri 64108 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Ohio State University Medical Center (OSUMC) Columbus Ohio 43210 —
Oregon Health & Science University Portland Oregon 97239 —
Children's Hospital of Philadelphia (CHOP) Philadelphia Pennsylvania 19104 —
The University of Texas Southwestern Medical Center Dallas Texas 75390 —
Virginia Commonwealth University Richmond Virginia 23284 —
Fred Hutchinson Cancer Research Center Seattle Washington 98109 —
Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04390113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04390113 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →